DE3750710T2 - Ester von Alginsäure. - Google Patents

Ester von Alginsäure.

Info

Publication number
DE3750710T2
DE3750710T2 DE3750710T DE3750710T DE3750710T2 DE 3750710 T2 DE3750710 T2 DE 3750710T2 DE 3750710 T DE3750710 T DE 3750710T DE 3750710 T DE3750710 T DE 3750710T DE 3750710 T2 DE3750710 T2 DE 3750710T2
Authority
DE
Germany
Prior art keywords
esters
alginic acid
alginic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3750710T
Other languages
English (en)
Other versions
DE3750710D1 (de
Inventor
Valle Francesco Della
Aurelio Romeo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of DE3750710D1 publication Critical patent/DE3750710D1/de
Application granted granted Critical
Publication of DE3750710T2 publication Critical patent/DE3750710T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
DE3750710T 1986-06-30 1987-06-25 Ester von Alginsäure. Expired - Fee Related DE3750710T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48201/86A IT1203814B (it) 1986-06-30 1986-06-30 Esteri dell'acido alginico

Publications (2)

Publication Number Publication Date
DE3750710D1 DE3750710D1 (de) 1994-12-08
DE3750710T2 true DE3750710T2 (de) 1995-03-16

Family

ID=11265177

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750710T Expired - Fee Related DE3750710T2 (de) 1986-06-30 1987-06-25 Ester von Alginsäure.

Country Status (24)

Country Link
US (1) US5336668A (de)
EP (2) EP0251905B1 (de)
JP (2) JP2569054B2 (de)
CN (1) CN1026001C (de)
AR (1) AR242959A1 (de)
AT (1) ATE113610T1 (de)
AU (2) AU602901B2 (de)
CA (1) CA1338235C (de)
DE (1) DE3750710T2 (de)
DK (1) DK333687A (de)
EG (1) EG18197A (de)
FI (1) FI872878A (de)
HU (1) HU202559B (de)
IL (1) IL82943A (de)
IN (1) IN166549B (de)
IT (1) IT1203814B (de)
MX (1) MX7108A (de)
NO (1) NO175059B (de)
NZ (1) NZ220807A (de)
PH (1) PH25729A (de)
PL (1) PL157922B1 (de)
PT (1) PT85200B (de)
YU (2) YU46960B (de)
ZA (1) ZA874520B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264422A (en) * 1986-06-30 1993-11-23 Fidia S.P.A. Esters of alginic acid with steroidal alcohols
DK110188D0 (da) * 1988-03-02 1988-03-02 Claus Selch Larsen High molecular weight prodrug derivatives of antiinflammatory drugs
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici
JP2627344B2 (ja) * 1990-01-23 1997-07-02 工業技術院長 水溶性アルギン繊維及びその製造方法
ES2087471T3 (es) * 1991-02-11 1996-07-16 Fidia Spa Esteres gelan.
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
IT1263755B (it) * 1991-09-16 1996-08-29 Fidia Spa Uso di esteri della colina con polisaccaridi acidi come agenti antiulcera e gastroprotettivi
JPH07503943A (ja) * 1991-10-29 1995-04-27 クローバー　コンソリデイテッド，リミテッド 封入及び薬剤放出に有用な架橋性の多糖類、ポリカチオン及び脂質
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
US5824335A (en) * 1991-12-18 1998-10-20 Dorigatti; Franco Non-woven fabric material comprising auto-crosslinked hyaluronic acid derivatives
IT1254170B (it) * 1991-12-18 1995-09-11 Mini Ricerca Scient Tecnolog Membrane composite per la rigenerazione guidata di tessuti
FR2699545B1 (fr) * 1992-12-18 1995-01-27 Oreal Agent gélifiant résultant de l'association d'un chitosane et d'un alginate d'alkyle ou d'hydroxyalkyle et son utilisation dans la préparation de compositions cosmétiques et pharmaceutiques.
IT1263394B (it) * 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
IT1268955B1 (it) * 1994-03-11 1997-03-18 Fidia Advanced Biopolymers Srl Esteri attivi di polisaccaridi carbossilici
IL114193A (en) * 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
ES2179930T3 (es) * 1995-02-07 2003-02-01 Fidia Advanced Biopolymers Srl Procedimiento para el recubrimiento de objetos con acido hialuronico, derivados del mismo y polimeros semisinteticos.
IT1281886B1 (it) * 1995-05-22 1998-03-03 Fidia Advanced Biopolymers Srl Processo per la preparazione di idrogel ottenuti da derivati chimici dell'acido ialuronico mediante irradiazioni ultraviolette e loro
FR2764505B1 (fr) * 1997-06-13 1999-10-15 Alain Dogliani Nouvelles compositions cosmetiques a base de lyophilisats d'alginates alcalins et nouveaux vecteurs de penetration
IT1294797B1 (it) 1997-07-28 1999-04-15 Fidia Advanced Biopolymers Srl Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante
FR2778081B1 (fr) * 1998-04-29 2000-08-25 Fabrice Thevenet Implants de renfort pour sutures tissulaires
FR2781677B1 (fr) * 1998-07-31 2000-10-20 Brothier Lab Dispositif de traitement de plaies et procede de fabrication de ce dispositif
EP1117444A2 (de) * 1998-10-09 2001-07-25 The University Of Michigan Wasserlösliche polymere träger zur arzneimittelabgabe
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
JP3814224B2 (ja) * 2001-04-25 2006-08-23 エーザイ株式会社 外用組成物
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
BR0314227A (pt) 2002-09-11 2005-10-25 Fresenius Kabi De Gmbh Derivados de amido de hidroxialquila
DE60323756D1 (de) 2002-10-08 2008-11-06 Fresenius Kabi De Gmbh Pharmazeutisch aktive oligosaccharid-conjugate
FR2850281A1 (fr) * 2003-01-27 2004-07-30 Brothier Lab Procede de fabrication d'un dispositif de renfort de suture
US7008476B2 (en) * 2003-06-11 2006-03-07 Az Electronic Materials Usa Corp. Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
GB2404920A (en) * 2003-08-12 2005-02-16 Johnson & Johnson Medical Ltd Antimicrobial polymer
WO2005030257A2 (en) * 2003-09-30 2005-04-07 Solubest Ltd. Water soluble nanoparticles inclusion complexes
JP5191729B2 (ja) 2004-03-11 2013-05-08 フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 還元的アミノ化によって製造される、ヒドロキシアルキルデンプンとタンパク質とのコンジュゲート
AR048709A1 (es) * 2004-04-26 2006-05-17 Cp Kelco Aps Composicion dermoprotectora para controlar la alcalinidad y uso de la misma
DE102004025495A1 (de) 2004-05-21 2005-12-15 Dr. Suwelack Skin & Health Care Ag Verfahren zur Herstellung von Alginat-haltigen porösen Formkörpern
GB0513552D0 (en) 2005-07-01 2005-08-10 Bristol Myers Squibb Co Bandage
DE102005049833A1 (de) * 2005-10-14 2007-04-19 Beiersdorf Ag Hydrophob modifizierte Alginate
EP2070950A1 (de) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkylstärkederivate und deren Herstellungsverfahren
FR2936800B1 (fr) * 2008-10-06 2010-12-31 Adocia Polysaccharide comportant des groupes fonctionnels carboxyles substitues par un derive d'alcool hydrophobe
US8426382B2 (en) 2008-10-06 2013-04-23 Adocia Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
JP2010106068A (ja) * 2008-10-28 2010-05-13 Mie Prefecture 多糖類の新規化学修飾法
WO2010069519A1 (en) * 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7
WO2012085609A1 (en) 2010-12-20 2012-06-28 Dept. Of Pathobiology Treatment of osteoarthritis by continuous intra-articular injection of alginate gel
EP4083074A1 (de) 2011-06-02 2022-11-02 Massachusetts Institute Of Technology Modifizierte alginate für zellverkapselung und zelltherapie
DE102012208321A1 (de) 2012-05-18 2013-11-21 Robert Bosch Gmbh Alginate als Binder für Batterie-Kathoden
KR102447142B1 (ko) 2014-05-19 2022-09-28 에어로젤-잇 게엠베하 다공성 알긴산염계 에어로겔의 제조 방법
WO2016019391A1 (en) * 2014-08-01 2016-02-04 Massachusetts Institute Of Technology Modified alginates for anti-fibrotic materials and applications
EP3368085B1 (de) 2015-11-01 2024-01-03 Massachusetts Institute Of Technology Modifizierte alginate für antifibrotische materialien und anwendungen
WO2017218520A1 (en) 2016-06-13 2017-12-21 Massachusetts Institute Of Technology Surface-coated continuous glucose monitors
WO2019090309A1 (en) 2017-11-06 2019-05-09 Massachusetts Institute Of Technology Anti-inflammatory coatings to improve biocompatibility of neurological implants
EP3773464A1 (de) 2018-04-09 2021-02-17 Basf Se Aerogele und deren verwendung in kosmetischen anwendungen
CN109646705B (zh) * 2019-01-30 2022-06-14 深圳齐康医疗器械有限公司 复合海绵及其制备方法和负压引流敷料、装置与医疗设备
CN110946712B (zh) * 2019-12-31 2021-06-18 露乐健康科技股份有限公司 具有柔臀健脂护理功能的纸尿裤
CN111518226A (zh) * 2020-03-06 2020-08-11 沈阳科技学院 一种用于活性染料直接印花的印花糊料的制备方法
CN113208953A (zh) * 2021-04-16 2021-08-06 青岛海之林生物科技开发有限公司 一种海藻染发膏及其制备工艺
CN115850533B (zh) * 2022-09-28 2023-07-21 青岛格诚经纬生物科技有限公司 一种海藻酸材料及其制备方法、应用

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA499026A (en) * 1954-01-05 B. Steiner Arnold Alkylene glycol esters of alginic acid
US2158487A (en) * 1935-10-22 1939-05-16 Kelco Co Triethanolamine alginate product and process
US2426125A (en) * 1944-04-03 1947-08-19 Kelco Co Manufacture of glycol alginates
US2477861A (en) * 1945-11-28 1949-08-02 Donald E Clark Production of fibrous watersoluble alginates
US2494912A (en) * 1947-01-20 1950-01-17 Kelco Co Higher alkylene glycol esters of alginic acid
US2478988A (en) * 1947-03-05 1949-08-16 Walierstein Company Inc Process for improving the foam of fermented malt beverages and product obtained thereby
US2463824A (en) * 1947-08-02 1949-03-08 Kelco Co Substituted alkylene glycol esters of alginic acid
US2647035A (en) * 1951-06-30 1953-07-28 Celanese Corp Dyeing of textile materials using alkylamine alginate thickeners
US2694058A (en) * 1951-10-20 1954-11-09 Hoffmann La Roche Production of polyuronic acid derivatives
US3108042A (en) * 1952-04-07 1963-10-22 Lilly Co Eli Corticotropin reaction complexes
GB768309A (en) * 1954-03-27 1957-02-13 Henkel & Cie Gmbh Process for the production of amides of alginic acid
US2860130A (en) * 1954-11-01 1958-11-11 Kelco Co Methyl alginate
GB833946A (en) * 1957-03-08 1960-05-04 Nordson Pharmaceutical Lab Inc L-amphetamine alginate
US3115488A (en) * 1960-02-29 1963-12-24 American Home Prod Alginic acid methyl ester sulfates, preparation and molecular weight fractionation thereof
US3115458A (en) * 1960-05-11 1963-12-24 Michael J Bebech Apparatus for filtering liquids
GB976301A (en) * 1960-10-27 1964-11-25 Calmic Ltd Preparation and use of alginates
NL273693A (de) * 1961-01-18
US3787389A (en) * 1961-04-24 1974-01-22 Purdue Frederick Co Pyrazolidone derivatives
US3790558A (en) * 1961-04-24 1974-02-05 Purdue Frederick Co Pyrazolidone derivatives substituted on the 4 position with pectin or algin
US3332933A (en) * 1964-02-21 1967-07-25 Kelco Co Diacyl n-alkyl ammonium alginates and their preparation
US3325472A (en) * 1964-06-18 1967-06-13 Mortimer D Sackler Polycyclohexose-polyoxyethyleneglycol suppository bases
US3450814A (en) * 1964-07-15 1969-06-17 Chemway Corp Ophthalmic compositions containing alginic acid salts of pilocarpine,atropine and physostigmine
US3351581A (en) * 1966-06-24 1967-11-07 Kelco Co Acetyl alginates and pectates and process of making the same
US4003792A (en) * 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
GB1174854A (en) * 1967-07-07 1969-12-17 Miles Lab New Biologically Active Conjugates
US3535308A (en) * 1968-01-15 1970-10-20 American Cyanamid Co Process for the preparation of partially esterified polyhydroxylic polymers
US3574641A (en) * 1968-03-29 1971-04-13 Kelco Co High neutralized propylene glycol alginate in french dressing
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US3993073A (en) * 1969-04-01 1976-11-23 Alza Corporation Novel drug delivery device
DK125598B (da) * 1969-09-29 1973-03-12 Grindstedvaerket As Fremgangsmåde til fremstilling af propylenglykolalginat.
US3792164A (en) * 1970-03-31 1974-02-12 Chemway Corp Ophthalmic composition comprising water-soluble alkaloid salts of polyuronic acids
GB1355998A (en) * 1970-09-30 1974-06-12 Unilever Ltd Builders for detergent compositions
US3887175A (en) * 1970-11-19 1975-06-03 G A Cochard Lab Quinidine alginate and process of preparation thereof
CA942744A (en) * 1970-12-11 1974-02-26 David J. Pettitt Method for preparing propylene glycol esters of alginic acid
GB1375572A (de) * 1971-08-12 1974-11-27
GB1395898A (en) * 1971-09-28 1975-05-29 Berenguer Beneyto Lab Dihydroquinidine derivative
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
US4206301A (en) * 1972-09-28 1980-06-03 Seymour Yolles Sustained flavor release composition
US3772266A (en) * 1972-10-19 1973-11-13 Kelco Co Process for the preparation of propylene glycol alginate from partially neutralized alginic acid
US4178361A (en) * 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
FR2247204A1 (en) * 1973-10-16 1975-05-09 Girardiere Gf Veterinary aerosol foams - contg alginic acid derivs as film-formers for injection into cows teats, vagina or uterus
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4002731A (en) * 1974-06-17 1977-01-11 Sterling Drug Inc. Diagnostic process using sodium tyropanoate
CA1019326A (en) * 1974-07-16 1977-10-18 Uniroyal Ltd. Process for the production of alkylene glycol alginates
US4013820A (en) * 1974-11-07 1977-03-22 Abbott Laboratories Universally useable tableting ingredients
CA1057746A (en) * 1975-09-16 1979-07-03 Merck And Co. Propylene glycol alginic acid esters
US4104460A (en) * 1976-09-14 1978-08-01 Nobuyasu Hasebe Method for treating seaweed with hydrogen peroxide or hydrogen peroxide compound
AT358147B (de) * 1976-12-03 1980-08-25 Gergely Gerhard Reinigungsmaterial
FR2418821A1 (fr) * 1978-03-03 1979-09-28 Adeline Andre Procede de fabrication de fibres d'alginate de calcium
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4364929A (en) * 1979-04-02 1982-12-21 The Purdue Frederick Company Germicidal colloidal lubricating gels and method of producing the same
JPS5953951B2 (ja) * 1979-04-02 1984-12-27 住友化学工業株式会社 繊維材料の浸染法
SE442705B (sv) * 1979-05-08 1986-01-27 Viktor Kare Larsson Medel for bildande av ett skyddsskikt pa ett underlag i form av hud eller slemhinna samt forfarande for att bilda ett skyddsskikt pa huden i icke-terapeutiskt syfte med hjelp av detta medel
FR2482603A1 (fr) * 1980-05-14 1981-11-20 Pharmindustrie Nouveaux esters d'heparine utilisables pour la preparation de medicaments, et procedes pour leur preparation
JPS58206751A (ja) * 1982-05-26 1983-12-02 日石三菱株式会社 創傷被覆材
US4512987A (en) * 1982-07-15 1985-04-23 Ciba-Geigy Corporation New pharmaceutical preparations
US4500676A (en) * 1983-12-15 1985-02-19 Biomatrix, Inc. Hyaluronate modified polymeric articles
JPS60226832A (ja) * 1984-04-02 1985-11-12 Daicel Chem Ind Ltd 多糖の脂肪族エステルを含む分離剤
JPH0680081B2 (ja) * 1984-04-11 1994-10-12 ダイセル化学工業株式会社 多糖類誘導体
JPH0699482B2 (ja) * 1984-04-16 1994-12-07 ダイセル化学工業株式会社 多糖類誘導体
JPS6130516A (ja) * 1984-07-20 1986-02-12 Nichiban Co Ltd 粘膜付着製剤
DE3686275T2 (de) * 1985-01-11 1993-03-18 Teijin Ltd Praeparate mit verzoegerter freisetzung.
US4818751A (en) * 1985-07-02 1989-04-04 Zeria Shinyaku Kogyo Kabushiki Kaisha Cosmetics
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
GB8519416D0 (en) * 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
SE452469B (sv) * 1986-06-18 1987-11-30 Pharmacia Ab Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
US5147861A (en) * 1986-06-30 1992-09-15 Fidia S.P.A. Esters of alginic acid
US4808707A (en) * 1987-06-08 1989-02-28 University Of Delaware Chitosan alginate capsules

Also Published As

Publication number Publication date
MX7108A (es) 1994-01-31
AU7008491A (en) 1991-05-16
JPS6333401A (ja) 1988-02-13
FI872878A (fi) 1987-12-31
HUT43870A (en) 1987-12-28
YU46960B (sh) 1994-09-09
AR242959A1 (es) 1993-06-30
AU651804B2 (en) 1994-08-04
CN1026001C (zh) 1994-09-28
JPH08311104A (ja) 1996-11-26
DK333687D0 (da) 1987-06-29
EP0251905B1 (de) 1994-11-02
DE3750710D1 (de) 1994-12-08
EG18197A (en) 1992-09-30
EP0609968A3 (de) 1994-12-21
EP0251905A3 (en) 1988-07-20
YU46980B (sh) 1994-09-09
HU202559B (en) 1991-03-28
IL82943A (en) 1994-02-27
NO175059B (no) 1994-05-16
IT8648201A0 (it) 1986-06-30
EP0251905A2 (de) 1988-01-07
CA1338235C (en) 1996-04-09
ATE113610T1 (de) 1994-11-15
EP0609968A2 (de) 1994-08-10
JP2569054B2 (ja) 1997-01-08
IN166549B (de) 1990-06-02
CN87104499A (zh) 1988-04-06
AU7490987A (en) 1988-01-07
FI872878A0 (fi) 1987-06-30
AU602901B2 (en) 1990-11-01
PL157922B1 (en) 1992-07-31
NO175059C (de) 1994-08-24
IT1203814B (it) 1989-02-23
NZ220807A (en) 1992-03-26
US5336668A (en) 1994-08-09
PH25729A (en) 1991-10-18
DK333687A (da) 1987-12-31
YU84688A (en) 1989-10-31
ZA874520B (en) 1987-12-29
PT85200A (en) 1987-07-01
NO872716D0 (no) 1987-06-29
PL266544A1 (en) 1988-09-15
PT85200B (pt) 1990-03-30
NO872716L (no) 1988-01-04
IL82943A0 (en) 1987-12-20

Similar Documents

Publication Publication Date Title
DE3750710T2 (de) Ester von Alginsäure.
ATE163942T1 (de) Vernetzte ester von hyaluronsäure
DE3763968D1 (de) Ester von thiolcarboxylsaeuren.
ATE19401T1 (de) Epimerisierung von malonsaeureestern.
ATE142205T1 (de) Substituierte piperidimylmethyl-ester von 3- indolcarbonsäure
ATE42751T1 (de) Carboxylsaeureesterderivate von deglucoteicoplanin.
DE58902314D1 (de) Substituierte acrylsaeureester.
DK0384211T3 (da) Substituerede acrylsyreestere
DE3762613D1 (de) Verfahren zur razemisierung von optisch aktiver chrysanthemsaeure oder ihres esters.
DE3679213D1 (de) Herstellung von estern der butandikarbonsaeure.
DE3579228D1 (de) Hohes molekulargewicht von fluessigen estern.
DE3682827D1 (de) Herstellungsverfahren von estern der trans-alpha-benzoylacrylsaeure.
DE3888505D1 (de) Herstellung von Zimtsäureestern.
DK488088D0 (da) Fremgangsmaade til fremstilling af 1-aryl-3-pyrazol-3-carboxylsyreestere
DE3768542D1 (de) Herstellung von zimtsaeureestern.
ATE54909T1 (de) Ester von thiolcarboxylsaeuren.
DE3486091D1 (de) Herstellung von butandicarboxylsaeureestern.
DE3781376D1 (de) Herstellungsverfahren von 2-vinylcyclopropan-1,1-dicarbonsaeure-dialkylestern.
ES2010642B3 (es) Esteres alquilicos de l-aspartil-3-(bicicloalquil)-l-alanina.
DE68913040T2 (de) Herstellungsverfahren von essigsäure arylestern.
DE3783412D1 (de) Herstellungsverfahren von substituierten benzoesaeureestern.
DE69215932D1 (de) Ester von Pregna-21-säure
DE3580583D1 (de) Herstellung von arylestern.
SE8502932D0 (sv) Novel androstane-17beta-carboxylic acid esters
ATE55595T1 (de) Hohes molekulargewicht von fluessigen estern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee